Simpson Thacher represented the underwriters in the offering. Takeda Pharmaceutical Company Limited (“Takeda”) executed its $7 billion aggregate principal amount of Senior Notes. The Notes were…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
